Pilocarpine Hydrochloride Patent Expiration
Pilocarpine Hydrochloride is Used for correcting age-related loss of near vision (presbyopia). It was first introduced by Alcon Laboratories Inc
Pilocarpine Hydrochloride Patents
Given below is the list of patents protecting Pilocarpine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Qlosi | US10639297 | Ophthalmic pharmaceutical compositions and uses relating thereto | Aug 18, 2037 | Orasis Pharms |
| Qlosi | US11129812 | Ophthalmic pharmaceutical compositions and uses relating thereto | Aug 18, 2037 | Orasis Pharms |
| Qlosi | US9867810 | Ophthalmic pharmaceutical compositions and uses relating thereto | Aug 18, 2037 | Orasis Pharms |
| Vuity | US10610518 | Presbyopia treatments | Apr 24, 2039 | Abbvie |
| Vuity | US11285134 | Presbyopia treatments | Apr 24, 2039 | Abbvie |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Pilocarpine Hydrochloride's patents.
Latest Legal Activities on Pilocarpine Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Pilocarpine Hydrochloride.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Oct, 2023 | US10639297 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Sep, 2023 | US10610518 |
| Patent Issue Date Used in PTA Calculation | 29 Mar, 2022 | US11285134 |
| Recordation of Patent Grant Mailed | 29 Mar, 2022 | US11285134 |
| Email Notification | 10 Mar, 2022 | US11285134 |
| Issue Notification Mailed | 09 Mar, 2022 | US11285134 |
| Dispatch to FDC | 01 Mar, 2022 | US11285134 |
| Mail Post Card | 23 Feb, 2022 | US11285134 |
| Issue Fee Payment Received | 17 Feb, 2022 | US11285134 |
| Issue Fee Payment Verified | 17 Feb, 2022 | US11285134 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Pilocarpine Hydrochloride Generics
Several generic applications have been filed for Pilocarpine Hydrochloride. The first generic version for Pilocarpine Hydrochloride was by Padagis Us Llc and was approved on Nov 16, 2004. And the latest generic version is by Amneal Eu Ltd and was approved on Sep 21, 2020.
Given below is the list of companies who have filed for Pilocarpine Hydrochloride generic.
1. AMNEAL
Amneal Eu Ltd has filed for 3 different strengths of generic version for Pilocarpine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2% | solution | Prescription | OPHTHALMIC | AT | Sep 21, 2020 |
| 1% | solution | Prescription | OPHTHALMIC | AT | Sep 21, 2020 |
| 4% | solution | Prescription | OPHTHALMIC | AT | Sep 21, 2020 |
2. RISING
Rising Pharma Holdings Inc has filed for 3 different strengths of generic version for Pilocarpine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1% | solution | Prescription | OPHTHALMIC | AT | Sep 27, 2017 |
| 2% | solution | Prescription | OPHTHALMIC | AT | Sep 27, 2017 |
| 4% | solution | Prescription | OPHTHALMIC | AT | Sep 27, 2017 |
3. IMPAX LABS
Impax Laboratories Inc has filed for 2 different strengths of generic version for Pilocarpine Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Prescription | ORAL | AB | Mar 31, 2006 |
| 5MG | tablet | Prescription | ORAL | AB | Mar 31, 2006 |
4. LANNETT CO INC
Lannett Co Inc has filed for 2 different strengths of generic version for Pilocarpine Hydrochloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Oct 14, 2005 |
| 7.5MG | tablet | Prescription | ORAL | AB | May 6, 2009 |
5. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Pilocarpine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Aug 13, 2019 |
| 7.5MG | tablet | Prescription | ORAL | AB | Aug 13, 2019 |
6. SOMERSET THERAPS LLC
Somerset Therapeutics Llc has filed for 3 different strengths of generic version for Pilocarpine Hydrochloride. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1% | solution | Prescription | OPHTHALMIC | AT | Nov 25, 2019 |
| 2% | solution | Prescription | OPHTHALMIC | AT | Nov 25, 2019 |
| 4% | solution | Prescription | OPHTHALMIC | AT | Nov 25, 2019 |
7. PADAGIS US
Padagis Us Llc has filed for 1 generic for Pilocarpine Hydrochloride. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Nov 16, 2004 |
8. INNOGENIX
Innogenix Llc has filed for 2 different strengths of generic version for Pilocarpine Hydrochloride. Given below are the details of the strengths of this generic introduced by Innogenix.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Dec 22, 2004 |
| 7.5MG | tablet | Prescription | ORAL | AB | Feb 27, 2007 |